Selank is discussed online as a settled anti-anxiety peptide. The actual evidence is more geographically concentrated, and less independently replicated, than that framing suggests.
What Selank is
Selank is a synthetic peptide derived from tuftsin, developed at the Institute of Molecular Genetics in Moscow, studied for anxiolytic (anti-anxiety) and cognitive effects. It's registered as an anti-anxiety drug in Russia.
What's actually been studied
- Mechanistic work. Research has reported that Selank acts as a positive allosteric modulator of GABA binding and affects enkephalin and brain-derived neurotrophic factor (BDNF) expression, alongside changes in serotonin and dopamine turnover (mechanistic study, Frontiers in Pharmacology).
- BDNF effects in animals. In rats, intranasal Selank increased BDNF messenger RNA in the hippocampus within hours, with BDNF protein increases following within a day, animal work supporting a plausible mechanism for cognitive and mood effects.
- Russian clinical experience. Selank has been studied in Russian clinical practice for generalized anxiety disorder and neurasthenia, with reported anxiolytic activity and no sedation in comparator-controlled research, though specific effect sizes were not available in English-language reporting I could access.
Where the evidence is thin
This is a case where the geographic concentration of the evidence matters as much as its existence. The human clinical data comes almost entirely from the Russian research network that developed the compound, and no Western, independently run randomized controlled trials with pre-registered endpoints appear to have replicated the anxiolytic findings. That's a meaningfully different evidence picture than a compound whose developer's own trials have been confirmed by unrelated research groups elsewhere.
The regulatory picture
Selank is registered as an anti-anxiety medication in Russia. It is not FDA-approved in the United States. It's sold by research chemical vendors strictly for laboratory research, not for human use.
Papa's take
I don't think "developed and studied primarily by one country's research network" automatically means the findings are wrong, but it does mean the independent-replication bar hasn't been cleared yet by Western standards, and that's relevant information that tends to get left out of English-language summaries built for a US audience buying research peptides online.
Sources
Sourcing for research
If you're sourcing Selank for laboratory research, purity documentation matters. See my vendor comparisons for how I evaluate third-party certificates of analysis.